The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine or magrolimab for patients with CD123-positive acute myeloid leukemia (AML).
 
Naval Guastad Daver
Consulting or Advisory Role - Abbvie; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; Immunogen; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; SERVIER; Shattuck Labs; Stemline/Menarini; Syndax; Trillium Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); FATE Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immunogen (Inst); Kite, a Gilead company (Inst); Novimmune (Inst); Pfizer (Inst); Servier (Inst); Trillium Therapeutics (Inst); Trovagene (Inst)
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Astellas Oncology; BeiGene; Bristol-Myers Squibb; Incyte; Jazz Pharmaceuticals; Kura Oncology; Menarini; Novartis; Otsuka; Pfizer; Ryvu Therapeutics; Takeda
Speakers' Bureau - Abbvie; Astellas Oncology; Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Menarini (Inst); Novartis (Inst); Pfizer (Inst)
 
Ahmed M. Aribi
Consulting or Advisory Role - Seagen
 
Giovanni Martinelli
Consulting or Advisory Role - Abbvie; Astellas Oncology; Celgene/Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Incyte; Jazz Pharmaceuticals; Pfizer; Roche; Stemline Therapeutics
Speakers' Bureau - Astellas Oncology; Celgene/Bristol-Myers Squibb; Pfizer
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene/Bristol-Myers Squibb; Genentech; Gilead Sciences; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Pfizer; Pharmaessentia; PTC Therapeutics; Stemline Therapeutics; Takeda
Speakers' Bureau - Astellas Pharma; dava oncology; Kite, a Gilead company; Pfizer; Stemline Therapeutics
 
Jessica K. Altman
Consulting or Advisory Role - Abbvie; Astellas Pharma; BioSight; Bluebird Bio; Curio Science; Daiichi Sankyo/Lilly; Gilead Sciences; Gilead Sciences; GlycoMimetics; Kura Oncology; Stemline Therapeutics; Syros Pharmaceuticals
Research Funding - Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Amphivena (Inst); Aprea AB (Inst); Aptose Biosciences (Inst); Astellas Pharma (Inst); Biosight (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cyclacel (Inst); Fujifilm (Inst); Immunogen (Inst); Kartos Therapeutics (Inst); Kura Oncology (Inst); Kura Oncology (Inst); Loxo (Inst); Pfizer (Inst); Telios (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Biosight; Daiichi Sankyo
Other Relationship - Imedex/HMP; NCI; Peerview; Peerview
 
Gail J. Roboz
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Astellas Oncology; Astex Pharmaceuticals; Bayer; Bristol-Myers Squibb; Celgene; Celltrion; Daiichi Sankyo Pharmaceutical; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Janssen; Jasper Therapeutics; Jazz Pharmaceuticals; MedImmune; MEI Pharma; Mesoblast; Novartis; Otsuka; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Amphivena Therapeutics (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); CTI (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Amphivena Therapeutics; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Genentech/Roche; Jazz Pharmaceuticals; Novartis; Pfizer; Sunesis Pharmaceuticals
 
Patrick William Burke
Consulting or Advisory Role - Eisai (I); Lilly (I); Seagen (I)
Research Funding - Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - DAVA Pharmaceuticals
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Abbvie; Adicet Bio; BerGenBio; BiolineRx; Bristol-Myers Squibb/Celgene/Juno; Genentech; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Kronos; Kura Oncology; Orum Therapeutics; Pfizer; Stemline Therapeutics
Research Funding - Amgen (Inst); Aptevo Therapeutics; Arog (Inst); Celgene; Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead; Kura Oncology; Macrogenics (Inst); Pfizer; Selvita (Inst)
 
Kebede Begna
Consulting or Advisory Role - Novartis/Pfizer
 
Callum Mortimer Sloss
Employment - ImmunoGen
Stock and Other Ownership Interests - ImmunoGen
 
Kara E Malcolm
Employment - ImmunoGen
Stock and Other Ownership Interests - ImmunoGen
 
Patrick A Zweidler-McKay
Employment - Immunogen
Stock and Other Ownership Interests - Immunogen
Patents, Royalties, Other Intellectual Property - Patent applications submitted, no royalties
 
Kendra Lynn Sweet
Leadership - Immundex (I)
Honoraria - Curio Science
Consulting or Advisory Role - BerGenBio; Bristol-Myers Squibb; Curis; Daiichi Sankyo/Lilly; Gilead Sciences; Jazz Pharmaceuticals; Mablytics; Nkarta; Novartis; Pfizer
Research Funding - Incyte (Inst); Jazz Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Jazz Pharmaceuticals